ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages

Dwayne E. Dove, Yan Ru Su, Wenwu Zhang, W. Gray Jerome, Larry L. Swift, MacRae F. Linton, Sergio Fazio

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Objective - Acyl-coenzyme A: cholesterol acyltransferase (ACAT) converts intracellular free cholesterol (FC) into cholesteryl esters (CE) for storage in lipid droplets. Recent studies in our laboratory have shown that the deletion of the macrophage ACAT1 gene results in apoptosis and increased atherosclerotic lesion area in the aortas of hyperlipidemic mice. The objective of the current study was to elucidate the mechanism of the increased atherosclerosis. Methods and Results - CE storage and FC efflux were studied in ACAT1(-/-) peritoneal macrophages that were treated with acetylated low-density lipoprotein (acLDL). Our results show that efflux of cellular cholesterol was reduced by 25% in ACAT1-deficient cells compared with wild-type controls. This decrease occurred despite the upregulated expression of ABCA1, an important mediator of cholesterol efflux. In contrast, ACAT1 deficiency increased efflux of the cholesterol derived from acLDL by 32%. ACAT1-deficient macrophages also showed a 26% increase in the accumulation of FC derived from acLDL, which was associated with a 75% increase in the number of intracellular vesicles. Conclusions - Together, these data show that macrophage ACAT1 influences the efflux of both cellular and lipoprotein-derived cholesterol and propose a pathway for the pro-atherogenic transformation of ACAT1(-/-) macrophages.

Original languageEnglish (US)
Pages (from-to)128-134
Number of pages7
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume25
Issue number1
DOIs
StatePublished - Jan 2005
Externally publishedYes

Fingerprint

Macrophages
Cholesterol
Cholesterol Esters
Sterol O-Acyltransferase
Acyl Coenzyme A
Peritoneal Macrophages
Aorta
Atherosclerosis
Apoptosis
Genes
acetyl-LDL

Keywords

  • ACAT1
  • Atherosclerosis
  • ATP-binding cassette A1
  • Cholesterol efflux
  • Macrophages

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages. / Dove, Dwayne E.; Su, Yan Ru; Zhang, Wenwu; Jerome, W. Gray; Swift, Larry L.; Linton, MacRae F.; Fazio, Sergio.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 25, No. 1, 01.2005, p. 128-134.

Research output: Contribution to journalArticle

Dove, Dwayne E. ; Su, Yan Ru ; Zhang, Wenwu ; Jerome, W. Gray ; Swift, Larry L. ; Linton, MacRae F. ; Fazio, Sergio. / ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2005 ; Vol. 25, No. 1. pp. 128-134.
@article{5d9101da35004ce9964153455a84dbb3,
title = "ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages",
abstract = "Objective - Acyl-coenzyme A: cholesterol acyltransferase (ACAT) converts intracellular free cholesterol (FC) into cholesteryl esters (CE) for storage in lipid droplets. Recent studies in our laboratory have shown that the deletion of the macrophage ACAT1 gene results in apoptosis and increased atherosclerotic lesion area in the aortas of hyperlipidemic mice. The objective of the current study was to elucidate the mechanism of the increased atherosclerosis. Methods and Results - CE storage and FC efflux were studied in ACAT1(-/-) peritoneal macrophages that were treated with acetylated low-density lipoprotein (acLDL). Our results show that efflux of cellular cholesterol was reduced by 25{\%} in ACAT1-deficient cells compared with wild-type controls. This decrease occurred despite the upregulated expression of ABCA1, an important mediator of cholesterol efflux. In contrast, ACAT1 deficiency increased efflux of the cholesterol derived from acLDL by 32{\%}. ACAT1-deficient macrophages also showed a 26{\%} increase in the accumulation of FC derived from acLDL, which was associated with a 75{\%} increase in the number of intracellular vesicles. Conclusions - Together, these data show that macrophage ACAT1 influences the efflux of both cellular and lipoprotein-derived cholesterol and propose a pathway for the pro-atherogenic transformation of ACAT1(-/-) macrophages.",
keywords = "ACAT1, Atherosclerosis, ATP-binding cassette A1, Cholesterol efflux, Macrophages",
author = "Dove, {Dwayne E.} and Su, {Yan Ru} and Wenwu Zhang and Jerome, {W. Gray} and Swift, {Larry L.} and Linton, {MacRae F.} and Sergio Fazio",
year = "2005",
month = "1",
doi = "10.1161/01.ATV.0000148323.94021.e5",
language = "English (US)",
volume = "25",
pages = "128--134",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages

AU - Dove, Dwayne E.

AU - Su, Yan Ru

AU - Zhang, Wenwu

AU - Jerome, W. Gray

AU - Swift, Larry L.

AU - Linton, MacRae F.

AU - Fazio, Sergio

PY - 2005/1

Y1 - 2005/1

N2 - Objective - Acyl-coenzyme A: cholesterol acyltransferase (ACAT) converts intracellular free cholesterol (FC) into cholesteryl esters (CE) for storage in lipid droplets. Recent studies in our laboratory have shown that the deletion of the macrophage ACAT1 gene results in apoptosis and increased atherosclerotic lesion area in the aortas of hyperlipidemic mice. The objective of the current study was to elucidate the mechanism of the increased atherosclerosis. Methods and Results - CE storage and FC efflux were studied in ACAT1(-/-) peritoneal macrophages that were treated with acetylated low-density lipoprotein (acLDL). Our results show that efflux of cellular cholesterol was reduced by 25% in ACAT1-deficient cells compared with wild-type controls. This decrease occurred despite the upregulated expression of ABCA1, an important mediator of cholesterol efflux. In contrast, ACAT1 deficiency increased efflux of the cholesterol derived from acLDL by 32%. ACAT1-deficient macrophages also showed a 26% increase in the accumulation of FC derived from acLDL, which was associated with a 75% increase in the number of intracellular vesicles. Conclusions - Together, these data show that macrophage ACAT1 influences the efflux of both cellular and lipoprotein-derived cholesterol and propose a pathway for the pro-atherogenic transformation of ACAT1(-/-) macrophages.

AB - Objective - Acyl-coenzyme A: cholesterol acyltransferase (ACAT) converts intracellular free cholesterol (FC) into cholesteryl esters (CE) for storage in lipid droplets. Recent studies in our laboratory have shown that the deletion of the macrophage ACAT1 gene results in apoptosis and increased atherosclerotic lesion area in the aortas of hyperlipidemic mice. The objective of the current study was to elucidate the mechanism of the increased atherosclerosis. Methods and Results - CE storage and FC efflux were studied in ACAT1(-/-) peritoneal macrophages that were treated with acetylated low-density lipoprotein (acLDL). Our results show that efflux of cellular cholesterol was reduced by 25% in ACAT1-deficient cells compared with wild-type controls. This decrease occurred despite the upregulated expression of ABCA1, an important mediator of cholesterol efflux. In contrast, ACAT1 deficiency increased efflux of the cholesterol derived from acLDL by 32%. ACAT1-deficient macrophages also showed a 26% increase in the accumulation of FC derived from acLDL, which was associated with a 75% increase in the number of intracellular vesicles. Conclusions - Together, these data show that macrophage ACAT1 influences the efflux of both cellular and lipoprotein-derived cholesterol and propose a pathway for the pro-atherogenic transformation of ACAT1(-/-) macrophages.

KW - ACAT1

KW - Atherosclerosis

KW - ATP-binding cassette A1

KW - Cholesterol efflux

KW - Macrophages

UR - http://www.scopus.com/inward/record.url?scp=11144227415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144227415&partnerID=8YFLogxK

U2 - 10.1161/01.ATV.0000148323.94021.e5

DO - 10.1161/01.ATV.0000148323.94021.e5

M3 - Article

C2 - 15499044

AN - SCOPUS:11144227415

VL - 25

SP - 128

EP - 134

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 1

ER -